Author/Authors :
Esfandiari Navid نويسنده , Sadeghi Masoud نويسنده Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran Sadeghi Masoud , Allahyari Abolghasem نويسنده Hematology Oncology Department, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran , Nazemian Fahimeh نويسنده Cancer Research Center,Shahid Beheshti University of Medical Sciences,Tehran,Iran
Abstract :
Introduction The coexistence of B-cell chronic lymphocytic
leukemia (CLL) and acute myeloid leukemia (AML) in the same patient is
rare. The aim of this study is to report of simultaneous occurrence of
CLL and AML M5 in an old female patient for the first time. Case
Presentation A 72-year-old woman referred to hematology clinic for
evaluation of leukocytosis, anemia, and thrombocytopenia. She had no
known history of chronic illness or exposure to radiation or myelotoxic
drugs. Physical examination showed the existence of generalized
lymphadenopathy and splenomegaly. Section of the biopsy core disclosed a
diffuse infiltration of lymphoid cells with hyperchromic irregular
nuclei and scant cytoplasm in the background. Immunohistochemical
staining for CD20 in lymphoid cells and CD68 in blastic cells were
positive but it was negative for terminal deoxynucleotidyl transferase
(TdT). The flow cytometric immunophenotyping analysis was performed in
the presence of CD5 positive B-cell population (CD19; CD20 dim; CD23 and
CD5/CD19) with small cell size that comprised 76% of cells with abnormal
phenotype was revealed. Simultaneous occurrence of CLL and AML M5 was
confirmed in the patients. Conclusions We report a case of previously
untreated CLL and AML M5 with rapidly progressive course to death in
less than one month from diagnosis. To the best of our knowledge, the
development of AML M5 in patient with CLL has not been reported before.